Aviir

Aviir

Signal active

Organization

Contact Information

Overview

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.

About

Industries

Biotechnology, Pharmaceutical, Health Diagnostics

Founded

2005

Employees

51-100

Headquarters locations

Irvine, California, United States, North America

Social

Profile Resume

Aviir headquartered in United States, North America, operates in the Biotechnology, Pharmaceutical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $10.9B in funding across 156 round(s). With a team of 51-100 employees, Aviir is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Aviir, raised $11.3M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

13

Investors

3

Lead Investors

0

Total Funding Amount

$69.9M

Details

5

Aviir has raised a total of $69.9M in funding over 5 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2007Early Stage Venture140.0K
2006Early Stage Venture1.5M
2013Early Stage Venture10.0M
2007Early Stage Venture11.3M

Investors

Aviir is funded by 52 investors.

Investor NameLead InvestorFunding RoundPartners
New Leaf Venture Partners-FUNDING ROUND - New Leaf Venture Partners11.3M
Paul Klingenstein-FUNDING ROUND - Paul Klingenstein11.3M
Aviir-FUNDING ROUND - Aviir11.3M
Aberdare Ventures-FUNDING ROUND - Aberdare Ventures11.3M